Lihui Zhang

Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: a dose-ranging, randomised, double-blind, placebo-controlled, phase 2 study

Dalong Zhu, Shenglian Gan, Yu Liu et al. · The Lancet Diabetes & Endocrinology · 2018 · 97 citations

Dorzagliatin Monotherapy, Diabetes Management, Medicine +7

A phase 2 randomised controlled trial of mazdutide in Chinese overweight adults or adults with obesity

Linong Ji, Hongwei� Jiang, Zhifeng Cheng et al. · Nature Communications · 2023 · 81 citations · Full text

Safety and effectiveness of metformin plus lifestyle intervention compared with lifestyle intervention alone in preventing progression to diabetes in a Chinese population with impaired glucose regulation: a multicentre, open-label, randomised controlled trial

Lihui Zhang, Yunliang Zhang, Sheng'ai Shen · The Lancet Diabetes & Endocrinology · 2023 · 76 citations

Obesity, Metabolic Syndrome, Diabetes Management +10

Chiglitazar monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomized, double-blind, phase 3 trial (CMAS)

Weiping Jia, Jianhua Ma, Heng Miao et al. · Science Bulletin · 2021 · 41 citations · Full text

USP5 promotes lipopolysaccharide-induced apoptosis and inflammatory response by stabilizing the TXNIP protein

Songchang Shi, Xiaobin Pan, Minyong Chen et al. · Hepatology Communications · 2023 · 11 citations · Full text